How the complex pharmacology of the fentanyls contributes to their lethality
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Academy of Medical Sciences (AMS‐SGCL13‐Gill)
- Medical Research Council (MR/N020669/1)
- Medical Research Council (MR/S010890/1)
- National Institute for Health and Care Research (CL‐2014‐25‐003)
- National Institute on Drug Abuse (RO1DA036975)
This publication has 18 references indexed in Scilit:
- Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive reviewNeuropharmacology, 2018
- Naloxone dosage for opioid reversal: current evidence and clinical implicationsTherapeutic Advances in Drug Safety, 2017
- Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid AnalgesicsCell, 2017
- Counterfeit Medications and FentanylJAMA Internal Medicine, 2016
- The toxicology of heroin-related death: estimating survival timesAddiction, 2016
- Ligand bias at the μ-opioid receptorBiochemical Society Transactions, 2013
- μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate InternalizationMolecular Pharmacology, 2010
- Morphine Side Effects in β-Arrestin 2 Knockout MiceThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Role Central Mu, Delta-1, and Kappa-1 Opioid Receptors in Opioid-induced Muscle Rigidity in the RatAnesthesiology, 1996
- Fentanyl-induced Rigidity and Unconsciousness in Human Volunteers Incidence, Duration, and Plasma ConcentrationsAnesthesiology, 1993